Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial-Reference-Cited by-同舟云学术

Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial

Published:2006-08-29 Issue:6 Volume:95 Page:717-721
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Seto T, ,Ushijima S,Yamamoto H,Ito K,Araki J,Inoue Y,Semba H,Ichinose Y

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6603319.pdf

Reference22 articles.

1. Chernow B, Sahn SA (1977) Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 63: 695–702

2. Desai SD, Figueredo A (1979) Intracavitary doxorubicin in malignant effusions. Lancet 1: 872 (letter)

3. Hartman DL, Gaither JM, Kesler KA, Mylet DM, Brown JW, Mathur PN (1993) Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg 105: 743–747 (discussion 747–748)

4. Hausheer FH, Yarbro JW (1985) Diagnosis and treatment of malignant pleural effusion. Semin Oncol 12: 54–75

5. Holoye PY, Jeffries DG, Dhingra HM, Holmes FA, Raber M, Engineer MS, Newman RA (1990) Intrapleural etoposide for malignant effusion. Cancer Chemother Pharmacol 26: 147–150

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant pleural disease;Breathe;2023-12

2. A phase II study of bevacizumab in non-squamous, non-small-cell lung cancer patients with malignant pleural effusion;Future Oncology;2022-02

3. A simple dilute-and-shoot procedure for the determination of platinum in human pleural effusions using HR-CS GF-AAS;Journal of Trace Elements in Medicine and Biology;2021-12

4. Prognosis of EGFR-mutant Lung Adenocarcinoma Patients With Malignant Pleural Effusion Receiving First-line EGFR-TKI Therapy Without Pleurodesis: A Single-institute Retrospective Study;Anticancer Research;2020-02

5. Prognostic Immune Cell Profiling of Malignant Pleural Effusion Patients by Computerized Immunohistochemical and Transcriptional Analysis;Cancers;2019-12-05